New Key Statistics Module, Z-Score and F-Score
NAS:HRTX Key Ratios
Market Cap $ M | 287.41 |
Enterprise Value $ M | 403.33 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 270.03 |
Price/Book | -- |
Price/Sales | 2.08 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 136.00 |
EPS (TTM) $ | -0.30 |
Beneish M-Score | -3.28 |
10-y EBITDA Growth Rate % | 10.40 |
5-y EBITDA Growth Rate % | 18.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -9.52 |
EV-to-EBITDA | -10.18 |
PEG | -- |
Shares Outstanding M | 151.67 |
Net Margin (%) | -35.29 |
Operating Margin % | -34.02 |
Pre-tax Margin (%) | -35.29 |
Quick Ratio | 1.85 |
Current Ratio | 2.38 |
ROA % (ttm) | -22.10 |
ROE % (ttm) | -- |
ROIC % (ttm) | -61.04 |
Dividend Yield % | -- |
Altman Z-Score | -11.12 |
HRTX Number of Guru Trades
HRTX Volume of Guru Trades
Gurus Latest Trades with NAS:HRTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HRTX is held by these investors
Total 1
Heron Therapeutics Inc Insider Transactions
No Available Data
News about NAS:HRTX
Total 0- 1